Fig. 1.

Bar graphs show the comparison of (a) accelerated idioventricular rhythm; (b) frequent ventricular premature beat; and (c) ventricular tachycardia between the placebo-treated and rhBNP-treated groups. *p < 0.05; NS: not significant; rhBNP: recombinant human B-type natriuretic peptide